Description
Zejula (niraparib) is a PARP inhibitor used in the treatment of certain gynaecological cancers including ovarian cancer.
$6,481.47
PARP inhibitor for gynaecological cancers
Zejula (niraparib) is a PARP inhibitor used in the treatment of certain gynaecological cancers including ovarian cancer.
Reviews
There are no reviews yet.